References
- Santini, C., Pellei, M., Gandin, V., Porchia, M., Tisato, F., Marzano, C. (2014) Advances in copper complexes as anticancer agents. Chem Rev 114:815–862.
- Li, D.D., Zhang, N., Dai, L.L., Yang, Z.B, Tao, Z.W. (2016). Synthesis, DNA binding, nuclease activity and cytotoxic studies of a wheel-shaped octanuclear copper(II) complex based on 1,2,4-triazole. Appl Organometal Chem 30:346–353.
- Qi, J.X., Liang, S.C., Gou, Y.,, Zhang Z.L., Zhou, Z.P., Yang, F., Liang, H. (2015) Synthesis of four binuclear copper(II) complexes: structure, anticancer properties and anticancer mechanism. Eur J Med Chem 96:360–368.
- Denoyer D, Masaldan S, La Fontaine S, Cater M.A (2015). Targeting copper in cancer therapy: ‘copper that cancer’. Metallomics 7:1459–1476.
- Lintnerová L, Valentová J, Herich P, Kožíšek J, Devínsky F (2018). Synthesis and antiradical activity of novel copper(II) complexes of long chain reduced Schiff base ligands. Monatsh Chem – Chem Mon 149:901–911.
- Cole, K. D., Tellez, C. M. (2002). Separation of large circular DNA by electrophoresis in agarose gels. Biotechnology progress 18(1):82–87.
- Kumar, A., et al.(2012). Cu (II) complexes of glyco-iminoaromatic conjugates in DNA binding, plasmid cleavage and cell cytotoxicity. J Chem Sci 124(6):1217–1228.
- Bitacura, J. G. (2018). The Use of Baker’s Yeast in the Resazurin Reduction Test: A Simple, Low-Cost Method for Determining Cell Viability in Proliferation and Cytotoxicity Assays. J Microbio. Biol Educ 19 (2):19–87. DOI: https://doi.org/10.1128/jmbe.v19i2.1599
- Botstein, D., Cherviz, S.A., Cherry, J.M. (1997). Yeast as a model organism. Science 277(5330):1259–1260.
- Borra, R.C., Lotufo, M.A., Gagioti, S.M., Barros, F.D.M., Andrade, P.M. (2009). A simple method to measure cell viability in proliferation and cytotoxicity assays. Braz Oral Res 23(3):255–262.
- Matuo, R., Sousa, F.G., Soares, D.G., Bonatto, D., Saffi, J., Escargueil, A.E., Larsen, A.K., Henriques, J.A. (2012). Saccharomyces cerevisiae as a model system to study the response to anticancer agents. Cancer Chemother Pharmacol 70:491–502.